LCM
VRTX icon

Logan Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Logan Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$993 Buy
+2
New +$886 ﹤0.01% 416
2025
Q4 		– Sell
-2
Closed -$783 – 470
2025
Q3 		$783 Hold
2
– – ﹤0.01% 440
2025
Q2 		$890 Hold
2
– – ﹤0.01% 433
2025
Q1 		$970 Hold
2
– – ﹤0.01% 516
2024
Q4 		$805 Buy
+2
New +$927 ﹤0.01% 493

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Logan Capital Management's VRTX Position: Q2 2026 in Review

Logan Capital Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 2 shares worth $993. The stake represents ﹤0.01% of the portfolio and ranks #416 among its holdings. This is a return to the name: Logan Capital Management previously reported a position in VRTX as recently as Q3 2025.

Logan Capital Management first reported a position in VRTX in Q4 2024 and has held it in 5 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Logan Capital Management held 2 shares of Vertex Pharmaceuticals worth $993 as of Q2 2026.
  • Vertex Pharmaceuticals was a new Logan Capital Management position in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Logan Capital Management's portfolio in Q2 2026, its #416 holding.
  • Logan Capital Management first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Logan Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.